Key result
Primary PCI is linked to ~55% lower 30-day mortality in AMI without cardiogenic shock.
Why the study?
Most patients with acute myocardial infarction present without cardiogenic shock, but few studies have specifically focused on their clinical characteristics and outcomes.
Does primary percutaneous coronary intervention (PPCI) improve survival and reduce in-hospital complications in patients presenting with acute myocardial infarction without cardiogenic shock?
Observational (n=176,275)
Yes
Does primary percutaneous coronary intervention (PPCI) improve survival and reduce in-hospital complications in patients presenting with acute myocardial infarction without cardiogenic shock?
Effect estimate: OR 0.45 (95% CI 0.42-0.49)
p-value: p=<0.001
In a large nationwide Japanese cohort of AMI patients without cardiogenic shock, primary PCI was independently associated with lower 30-day mortality and fewer in-hospital complications despite an aging population with increasing comorbidities.
BACKGROUND: Most patients with acute myocardial infarction (AMI) present in the emergency department in a hemodynamically stable condition (i.e., non-cardiogenic shock) (AMI-NCS). However, few studies specifically focused on the clinical characteristics and outcomes of AMI-NCS patients. Temporal trends in clinical characteristics, in-hospital occurrence of in-hospital adverse outcomes, and the effect of primary percutaneous coronary intervention (PPCI) were examined. METHODS AND RESULTS: Between April 2012 and March 2018, 176,275 AMI-NCS patients (67.7% of the total AMI population; 25.4% female; mean age 68.6±13.1 years) were identified in a nationwide Japanese administrative database. During the 6-year study period, AMI-NCS patients have been getting older and had an increasing burden of comorbidities. The rates of 30-day all-cause mortality and in-hospital complications were 2.6% and 30.5%, respectively. Thirty-day all-cause mortality did not change significantly over time, whereas in-hospital complications, especially major non-cardiac events, increased progressively. On multivariable analyses, higher age, higher Killip class, atrial fibrillation, chronic renal failure, and malignancy were independently associated with both increased 30-day mortality and in-hospital complications. PPCI was independently associated with lower mortality and in-hospital complications. CONCLUSIONS: The clinical background of AMI-NCS patients has been becoming more complex with increasing age and the burden of comorbidities, with increased in-hospital complications. More active and appropriate application of PPCI may further decrease adverse events and improve survival of AMI-NCS patients.
No takes yet. Share an insight, caveat, or question.
Okamoto et al. (2022) conducted an observational in Acute myocardial infarction without cardiogenic shock (AMI-NCS) (n=176,275). Primary percutaneous coronary intervention (PPCI) vs. No primary percutaneous coronary intervention was evaluated on 30-day all-cause mortality (OR 0.45, 95% CI 0.42-0.49, p=<0.001). Primary percutaneous coronary intervention was independently associated with a significant reduction in 30-day all-cause mortality (OR 0.45) in patients with acute myocardial infarction without cardiogenic shock.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: